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ABSTRACT 
 
Dynamic Whole Blood Study of Silicone Modified with PEO-Silane Amphiphiles 
 
Mikayla Barry 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Melissa Grunlan 
Department of Biomedical Engineering 
 
Blood-contacting medical devices rapidly adsorb plasma proteins that initiate clot (i.e. thrombus) 
formation. Antithrombotic drugs may reduce clotting and associated device dysfunction and 
ischemia, but put the patient at risk for hemorrhaging. Silicone, a common blood-contacting 
device material is highly prone to protein adsorption and subsequent clotting due to its extreme 
hydrophobicity. Poly(ethylene oxide) (PEO), a hydrophilic polymer, is highly protein resistant 
but its function when incorporated into silicone depends critically on its presence at the silicone-
water interface. To enable rapid and substantial migration of PEO to the silicone surface, a PEO-
silane amphiphile [α-(EtO)3Si(CH2)2-ODMS13-block-PEO8-OCH3]	 was prepared that bears the 
ability to substantially reduce fibrinogen adsorption on silicone, even at low concentrations. This 
work comprehensively evaluated the thromboresistance of a silicone modified with the PEO-
silane amphiphile via its exposure to whole blood under dynamic conditions using a Chandler 
Loop. Clotting was evaluated in terms of occlusion time and thrombus formation for silicones 
modified with varying levels of the PEO-silane amphiphile. Results demonstrated that 
concentrations as low as 10 µmol of amphiphile per gram of silicone were able to significantly 
reduce platelet adhesion and prevent occlusion during the course of the study. This indicates that 
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the amphiphiles are useful in preventing protein adhesion and obviating clot formation, 
increasing the safety and lifetime of implantable blood-contacting devices. 
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SECTION I 
INTRODUCTION 
 
Preventing thrombosis via PEO-additives 
Blood-contacting devices such as hemodialysis catheters must be thromboresistant, or capable of 
preventing clotting, in order to preserve patency. Silicone is commonly used to prepare catheters 
based on its favorable mechanical properties.1 Unfortunately, as a result of its hydrophobicity, 
silicone has a high affinity for protein adsorption making it very susceptible to thrombosis.2 
Consequently, patients utilizing silicone catheters or other medical devices composed of or 
coated with silicone must be placed on anti-thrombotic drugs to prevent clot formation. These 
drugs not only lead to an increased risk of bleeding complications, but also have demonstrated 
limited efficacy.2 A silicone material or coating that is inherently resistant to thrombosis could 
improve the safety of implantable devices and obviate the need for anti-thrombotics.  
 
Coatings made from poly(ethylene oxide) (PEO), a hydrophilic polymer, have shown the 
potential to resist protein adsorption by steric repulsion3 and blockage of adsorption sites.4 
Molecular simulations have also shown that PEO chains strongly associate with water via 
hydrogen bonding, creating a repulsive “hydration layer” that physically excludes 
macromolecules.4 While PEO’s protein resistance has been seen on materials with physically 
stable surfaces (e.g. silica or gold), grafted coatings on polymers have largely failed to prevent 
protein adsorption.5-7 This is likely due to PEO’s tendency to enter to the bulk of the polymer, 
particularly after exposure to air.8, 9 Therefore, in order to optimize PEO’s protein resistance, 
PEO must be able to spontaneously rise to the water-surface interface from the polymer matrix.  
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In previous studies, a (PEO)-silane amphiphile (Figure 1) was prepared10 to improve the 
thromboresistance of silicones by enhancing PEO migration to the surface. Unlike traditional 
non-amphiphilic PEO-silanes, this amphiphile includes a siloxane tether in order to enhance 
mobility of PEO within the silicone network and to the water-surface interface. When silicone 
was bulk-modified with this amphiphile and exposed to water, a remarkable increase in surface 
hydrophilicity and protein (fibrinogen) resistance was observed. This implies that the modified 
silicone has the potential to prevent clot formation. In this study, the thromboresistance of a 
silicone modified with the PEO-silane amphiphile was evaluated with a dynamic whole blood 
adhesion study using a Chandler Loop. 
 
 
Figure 1: PEO-silane amphiphile. 
 
Measuring coagulation 
Model framework 
Current methods of evaluating thromboresistance include measuring the partial thromboplastin 
time,11-13 platelet adhesion,12, 14-17 thrombin generation,13, 15, 18 protein (e.g. fibrinogen) 
adsorption,16, 19 and split products resulting from the coagulation cascade.20 However, each poses 
serious limitations. While its results are discriminative among similar materials, fibrinogen 
adsorption is incomplete in comparison to thrombin generation, as it only measures one of the 
clotting proteins found in blood13 and does not take the effect of protein conformation into 
account.21 It has also been found that partial thromboplastin time is not a reliable test method, 
particularly when comparing materials of similar hemocompatibility.13, 22 When evaluating 
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thromboresistance, researchers will often utilize two or more methods, where at least one is 
quantitative. A thrombin generation-based or platelet adhesion-based test that is consistent as 
well as discriminatory can act as the primary quantitative method in whole blood studies. Platelet 
adhesion is more commonly tested as it can be measured on the surface of the material as well as 
in solution. Static blood tests have been used for measuring platelet adhesion, but cannot 
accurately simulate thrombosis in vivo, which occurs with blood flow.23, 24 Dynamic tests better 
mimic the circulatory system environment, making them desirable for predicting efficacy in 
vivo.24  
 
Mechanical simulation 
Constructs for dynamic blood tests include parallel plate25, 26 as well as bioreactor flows.27 A 
relatively new construct is the Chandler Loop (Figure 2), wherein a tube shaped into a loop is 
partially filled with blood that flows continuously while the loop is rotated. Once the blood is 
removed, the entirety of the tube’s inner surface can be analyzed. This system, as a dynamic 
environment, better imitates the circulatory system relative to static conditions. With this setup, 
flow can be carefully tuned to match physiological shear rates and avoid turbulent flow.28-31 
Already in use for detecting thrombosis in stents,32, 33 the Chandler Loop has also recently been 
demonstrated as effective for evaluating silicone systems.34 It can thus be expected to provide 
results that are more representative of in vivo performance than static blood tests and be a viable 
construct for quantitative platelet adhesion tests. 
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Figure 2: Chandler Loop 
 
Data collection 
The adherence of platelets or proteins on materials can be compared qualitatively via imaging 
with SEM12, 35, 36 or confocal microscopy.14, 37 For quantitative analysis, flow cytometry28, 38, 39 as 
well as ELISA28 and a large variety of colorimetric and fluorescence assays (e.g. for Factor X27 
or LDH19) may be used. Flow cytometry, in which platelets are counted as they pass between a 
laser and an electrical detector, reports platelet concentration with high precision but requires the 
platelets to be in solution.40 A more direct approach could measure adhered platelets by 
measuring the concentration of proteins released into solution after membrane lysis. Lactate 
dehydrogenase (LDH) is expressed in nearly all living cells, as it catalyzes the conversion of 
lactate to pyruvate. A colorimetric LDH assay could be used as a simple and reliable method to 
quantify adhered platelets on a material surface.19, 27  
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SECTION II 
METHODS 
 
Materials 
Vinyltriethoxysilane (VTEOS) and α,ω-bis-(SiH)oligodimethylsiloxane [ODMS13; Mn = 1000–
1100 g/mol per manufacturer's specifications; Mn = 1096 g/mol per 1H NMR end group analysis; 
1H NMR (δ, ppm): 0.05–0.10 (m, 78H, SiCH3), 0.19 (d, J = 2.7 Hz, 12H, OSi[CH3]2H) and 4.67–
4.73 (m, 2H, SiH)], and Pt-divinyltetramethyldisiloxane complex (Karstedt’s catalyst) in xylene 
were purchased from Gelest. Allyl methyl PEO [Polyglykol AM 450, Mn = 292-644 g/mol per 
manufacturer’s specifications; Mn = 424 g/mol per 1H NMR end group analysis; 1H NMR (δ, 
ppm): 3.35 (s, 3H, OCH3), 3.51–3.66 (m, 32H, OCH2CH2), 4.00 (d, J = 5.4 Hz, 2H, 
CH2=CHCH2O), 5.13–5.28 (m, 2H, CH2=CHCH2O) and 5.82–5.96 (m, 1H, CH2=CHCH2O)] 
from Clariant was utilized. RTV medical-grade silicone (MED-1137) was purchased from NuSil 
Technology (Carpinteria, CA), composed of α,ω-bis-(Si-OH)polydimethylsiloxane, silica (11-
21%), methyltriacetoxysilane (<5%), ethyltriacetoxysilane (<5%), and trace amounts of acetic 
acid. Phosphate-buffered saline (PBS, without calcium and magnesium, pH = 7.4) and a PierceTM 
LDH Cytotoxicity Assay Kit were purchased from Fisher.	 RhCl(Ph3P)3 (Wilkinson’s catalyst) 
was obtained from Sigma-Aldrich. Organic solvents used were purchased from Sigma-Aldrich 
and were dried over 4 Å molecular sieves prior to use. 
 
Chandler Loop design and construction 
First, a stepper motor (Nema 17 – 12 V, 37 oz-in) paired with a driver (GE StepStick DRV8825) 
was combined with a voltage supply controller, consisting of an LCD Shield (SainSmart 1602) 
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user input interface linked to a microcontroller board (Arduino UNO R3). The controller was 
programmed to allow shaft rotation from 0 to 35 rpm in 5-rpm increments. A loop cradle was 
designed in SolidWorks and 3D printed to fit around the shaft of the stepper motor and extend 
radially outward. The entire apparatus (Figure 3) was secured by attaching the step motor to an 
L-shaped base that could then be bolted to a table. 
	
 
Figure 3: Finalized Chandler Loop construct. 
 
Test material preparation 
PEO-silane amphiphile synthesis 
The PEO-silane amphiphile was synthesized according to the procedure described by Murthy, et 
al.41 A triethoxysilane crosslinking group was first attached to one end of an 
oligodimethylsiloxane tether by performing a regioselective hydrosilylation reaction with 
VTEOS and ODMS13 for 16 hours using the Wilkinson’s catalyst. A Pt-catalyzed (Karstedt’s) 
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hydrosilylation reaction was then performed for 8 hours between the product and allyl PEO 
monomethyl ether of length n = 8, yielding the final amphiphile (Figure 4). 
 
 
Figure 4: Synthesis of PEO-silane amphiphiles. 
 
Modification of elastomer and application to tubing 
The PEO-silane amphiphile was added to Nusil MED-1137 RTV silicone at 5, 10, and 50 µmol 
per gram silicone. The mixtures were each diluted to 25 wt% in ethyl acetate. Poly(ethylene 
vinyl acetate) (EVA) tubing (1/8 in inner diameter, 40 cm length, McMaster-Carr) was exposed 
to oxygen plasma (time = 180 sec; Harrick Plasma PDC-001) to provide surface hydroxyl groups 
for improved adhesion of the modified silicone coating (i.e. those containing the PEO-silane 
amphiphile) and the unmodified silicone coating. For a given solvent-based mixture, 2.5 mL was 
poured into the EVA tubing and rotated at 5 rpm on the Chandler Loop for 30 minutes. Excess 
mixture was drained and the coated tubing was allowed to cure overnight. This coating process 
“Rh” (Wilkinson’s) 
   80 °C 
   16 h 
“Pt” (Karstedt’s) 
 80 °C 
 8 h 
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was repeated a second time. Finally, the tubing was rinsed once with 10 mL DI H2O to remove 
trace amounts of ethyl acetate. 
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Data collection 
Long-term occlusion study 
Citrated bovine blood was obtained from the Texas A&M Vet Med Park and used within 30 
minutes.42 Recalcified blood (1.6 mL, blood:0.1 M CaCl2 = 10:1, v/v) was poured into each 
coated tube and the blood-filled tubing was allowed to rotate in the Chandler Loop at 15 rpm. 
These conditions were determined to correspond to a strain rate of 272.5 s-1.31 Rotation was 
continued for a maximum of 24 hours or until clotting arrested blood flow. 
 
Platelet adhesion testing 
Citrated bovine blood was obtained from Texas A&M Vet Med Park and used within 30 
minutes.42 Recalcified blood (1.6 mL, blood:0.1 M CaCl2 = 10:1, v/v) was poured into unused 
coated tubing and the blood-filled tube rotated in the Chandler Loop at 15 rpm for 15 minutes.31 
Excess blood was removed, and the tubing was gently rinsed with 10 mL PBS to remove 
unbound cells.  
 
LDH assay 
A LDH cytotoxicity assay was performed per standard protocols.17 Three 2-cm sections of tubing 
were obtained from those used for platelet adhesion testing. Cells in these sections were lysed 
with 75 µL 0.7-1.0% poly(oxy-1,2-ethanediyl) for 45 minutes at 37 °C. From each section of 
tubing, 50 µL was then placed into an individual well in a 96-well microplate and 50 µL of the 
kit’s reaction mixture was added for 30 minutes before adding the kit’s stop solution. The 
absorbance of reaction products was measured with a microplate reader (Tecan Infinite® M200 
13 
	
PRO). The kit’s LDH positive control assay was used with bovine serum albumin (BSA) to 
develop a standard curve to determine protein concentration in the solution. 
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SECTION III 
RESULTS 
 
The thromboresistance of silicones modified with varying levels of the PEO-silane amphiphile 
(5, 10, and 50 µmol per gram silicone) were compared to that of unmodified silicone using a 
Chandler Loop. First, the time for occlusion to occur was assessed (Figure 5).  
 
 
Figure 5: Loop occlusion times for variable PEO-silane amphiphile concentration in silicone. 
 
The unmodified silicone coating was the least efficient, with an occlusion time of only 24.0 
minutes. For the silicone modified with only 5 µmol (0.86 wt%) of the amphiphile, occlusion 
time was modestly increased to 68.5 minutes. Upon increasing the amphiphile concentration to 
10 µmol (1.7 wt%) and 50 µmol (8.5 wt%), occlusion did not occur after 24 hours. 
 
In order to understand the occlusion time results, protein adsorption resulting from platelet 
adhesion were performed for modified and unmodified silicones. Figure 6 depicts relative 
0 4 8 12 16 20 24
Unmodified
5 µmol
10 µmol
50 µmol
Time (h)
Time to Occlusion
> 24 h 
> 24 h 
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platelet adsorption quantified by LDH assay following 15 minutes of exposure to whole blood in 
the Chandler Loop.  
 
 
Figure 6: Protein concentration from platelets adhered to modified silicones. 
 
Both the unmodified silicone and the silicone modified with 5 µmol PEO-silane amphiphile 
exhibited relatively high LDH concentration, indicating increased platelet adhesion. Notably, the 
unmodified silicone showed a significantly higher variance in protein concentration for different 
sections of the single loop. Protein concentration decreased substantially with increased 
concentration of amphiphile in the silicone. For silicones modified with 10 and 50 µmol 
amphiphile, protein concentration was 25 and <1% of that versus the unmodified silicone, 
respectively.  A substantial and concentration-dependent decrease in LDH concentration was 
observed, indicating a correlated decrease in platelet adhesion.19 Also, for the modified silicones, 
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protein adsorption was very consistent across the tubing. As predicted,19 these protein adsorption 
results correlate with the occlusion time observations (Figure 5).  
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SECTION IV 
CONCLUSION 
 
Preventing the premature failure of implantable medical devices resulting from thrombosis using 
a material modification approach presents a noteworthy alternative to the use of anticoagulants. 
A PEO-silane amphiphile developed by Grunlan and co-workers has shown promise in 
improving silicone resistance to the adsorption of fibrinogen. However, testing with whole blood 
was required to assess thrombogenicity of the modified silicones. To create a testing 
environment that simulates flow in vivo, a Chandler Loop was constructed and used for a whole 
blood dynamic in vitro test. Results indicate that the amphiphile significantly improves 
thromboresistance of the silicone at concentrations as low as 10 µmol per gram of silicone (1.7 
wt %). At a concentration of 50 µmol, platelet adhesion was nearly eliminated. 
 
Future directions can be taken to optimize the in vitro test before moving into in vivo studies. 
Recommended work includes modifying the Chandler Loop to match the in vivo body 
temperatures, identifying the minimum viable concentration of amphiphile, and assessing long-
term amphiphile efficacy in vitro. Additional testing should then be performed in an in vivo 
system. All of these will more comprehensively evaluate the functionality of the PEO-silane 
amphiphile in preventing protein adhesion. 
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